Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-20 of 20 for your search:
Drug:  omega-3 fatty acid
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 900/429/1, NCT00790140

2.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 30 to 65
Sponsor: Other
Protocol IDs: 88-04-27-9683, NCT01049295

3.

Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: OmegaDVS, NCT01803711

4.

Phase: Phase III
Type: Supportive care
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: 4086, NCT02294149

5.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Dietary intervention FL, NCT00455416

6.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 40 to 79
Sponsor: NCI, Other
Protocol IDs: 11165, R01CA160938, NCT01661764

7.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CCCWFU 98113, NCI-2013-00963, P30CA012197, NCT01869764

8.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 45 to 70
Sponsor: Other
Protocol IDs: STUDY00000703, NCT02101970

9.

Phase: Phase II
Type: Prevention
Status: Approved-not yet active
Age: 50 to 80
Sponsor: NCI, Other
Protocol IDs: 13-000432, NCI-2014-01257, P30CA016042, P50CA092131, NCT02176902

10.

Phase: Phase I
Type: Supportive care
Status: Active
Age: 2 to 18
Sponsor: Other
Protocol IDs: 20130321, NCT02134600

11.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: OSU-13130, 1R01CA164019-01A1, NCT02295059

12.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000538993, DFCI-03116, 03-116, NCT00458549

13.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 35 to 75
Sponsor: Other
Protocol IDs: INAF-2010-H09-10-114, NCT01653925

14.

Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 3-37878 L, NCT01704664

15.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: 30 to 55
Sponsor: Other
Protocol IDs: PSHCI 12-075, NCT01784042

16.

Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: INST 1211, NCI-2013-00443, NCT01821833

17.

Phase: No phase specified
Type: Supportive care
Status: Active
Age: 45 to 75
Sponsor: Other
Protocol IDs: MCC-17089, NCT01823991

18.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 25 and over
Sponsor: Other
Protocol IDs: 2012-0504, NCT01871350

19.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CTRC 13-0041, HSC20130426H, NCT02062255

20.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 to 75
Sponsor: Other
Protocol IDs: AAAL2650, NCT02278965
New Search